Hardy Diagnostics – Automating Colony Counting

SANTA MARIA, Calif., July 19, 2019 /PRNewswire/ — Hardy Diagnostics has designed an automated plate reader exclusively for the CompactDry™ plate line. The Wizard CompactDry™ Plate Reader will automate the task of manual colony counting on CompactDry™ plates for food samples. Manual colony counts can take hours to complete and results can vary from technician to technician. The Wizard CompactDry™ Plate Reader cuts read time down to seconds per plate, all while saving images for digital storage.

Furthermore, a competitive price point will allow labs of all sizes and throughputs to utilize automation for their colony counts and create standardization throughout their process. The Wizard CompactDry™ plate reader is available for purchase now.

CompactDry™ provides the tests needed to identify and enumerate some of the pathogens of concern in food safety, such as E. coli, coliforms, Salmonella, Listeria, Total Count, Enterobacteriaceae and more. Using a dry material source, rather than traditional agar, allows for room temperature storage of the plates and an increased shelf life. 

ADDITIONAL INFORMATION ABOUT HARDY DIAGNOSTICS – Hardy Diagnostics is an FDA licensed and ISO 13485 certified manufacturer of medical devices for microbiological procedures in both clinical and industrial laboratories. Hardy Diagnostics was founded in 1980 in Santa Barbara, California, by Jay Hardy and Robert Shibata after they completed their Medical Technology training in the laboratory at Santa Barbara Cottage Hospital.

Hardy Diagnostics manufactures over 2,700 different products for the culture and identification of bacteria and fungi. Among its offerings are products used to culture and detect pathogens commonly reported in the news, such as E. coliSalmonella, and Listeria. In addition, the company manufactures reagents and media for use by molecular biology researchers. Over 9,000 laboratories throughout the nation rely on Hardy Diagnostics for their supplies.

Today, Hardy Diagnostics is a 100% employee-owned company that employs over 375 people and maintains nine distribution centers throughout the U.S. Manufacturing takes place at its headquarters in Santa Maria, California and a secondary manufacturing facility in Springboro, Ohio. The company also exports products through over 65 foreign distributors. The company’s mission is to “partner with its laboratory customers to prevent and diagnose disease.” For more information, visit www.HardyDiagnostics.com.

MEDIA CONTACT:

Jessa Youngblood

Phone: 1-800-266-2222 x 5653

Email: Youngbloodj@HardyDiagnostics.com

Related Images

the-wizard-compactdry-plate-reader.jpg

Related Links

The Wizard

Compact Dry

Related Video

http://www.youtube.com/watch?v=-NrTQHek908

View original content:http://www.prnewswire.com/news-releases/hardy-diagnostics—automating-colony-counting-300888238.html

SOURCE Hardy Diagnostics

Staff

Recent Posts

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

4 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

7 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

7 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

7 hours ago

Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…

7 hours ago

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…

7 hours ago